Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Vitamin D Deficiency Could Affect Severity of Psychosis Symptoms

Publish date:: February 4, 2020

Key clinical point: Vitamin D could be considered as an add-on treatment for schizophrenia patients with low vitamin D levels.

Major finding: Low levels of 25-hydroxyvitamin D were significantly correlated with more severe depression, negative symptoms, and general psychopathology in first-episode psychosis patients.

Study details: The data come from a study of adults aged 18-45 years with affective and nonaffective first-episode psychosis.

Disclosures: The researchers disclosed no financial conflicts.

Citation:

Coentre R et al. Hindawi Psychiatry J. 2019. doi: 10.1155/2019/7839287.

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Schizophrenia & Other Psychotic Disorders

Risk factors for QTc prolongation during amisulpride therapy in schizophrenia,

Schizophrenia: Reinitiating clozapine can be considered in patients who have previously discontinued it,

Elevated IL-18 levels in patients with schizophrenia,

Schizophrenia: Antipsychotic choice may influence driving-related cognitive performance,

Treatment-resistant schizophrenia: Is slower-than-recommended titration of clozapine beneficial?,